Related Experiment Video
Updated: Jun 4, 2026
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Predicting response to immunosuppressive therapy in childhood aplastic anemia
Nao Yoshida1, Hiroshi Yagasaki, Asahito Hama
1Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Insights
Predicting response to aplastic anemia treatment is crucial. Lower white blood cell counts and prompt therapy improve outcomes in pediatric patients receiving immunosuppressive therapy.
Area of Science:
- Hematology
- Pediatric Oncology
- Immunology
Background:
- Predictive markers for response to immunosuppressive therapy (IST) in aplastic anemia (AA) are not well-defined.
- Aplastic anemia is a rare but serious condition characterized by bone marrow failure.
Purpose of the Study:
- To retrospectively evaluate pre-treatment clinical and laboratory findings as predictors of treatment response in pediatric aplastic anemia patients.
- To identify factors that could guide therapeutic decisions and improve patient outcomes.
Main Methods:
- Retrospective analysis of a pediatric cohort from the multicenter AA-97 study in Japan (1997-2006).
- 312 newly diagnosed children received combination therapy with antithymocyte globulin and cyclosporine.
- Multivariate analyses were performed to identify significant predictive markers.
Main Results:
- Lower white blood cell (WBC) count (<2.0×10(9)/L) was the most significant predictor of better treatment response (P=0.0003).
- Shorter interval between diagnosis and therapy (P=0.01) and male sex (P=0.03) were also associated with improved response rates.
- Higher WBC counts were linked to poorer response.
Conclusions:
- Pre-treatment clinical and laboratory findings significantly influence treatment response in pediatric aplastic anemia.
- Prompt initiation of immunosuppressive therapy is critical, as delays are associated with reduced response rates.
- Identifying predictive markers can optimize treatment strategies for aplastic anemia.
Abstract:
In aplastic anemia, predictive markers of response to immunosuppressive therapy have not been well defined. We retrospectively evaluated whether clinical and laboratory findings before treatment could predict response in a pediatric cohort from the multicenter AA-97 study in Japan. Between 1997 and 2006, 312 newly diagnosed children were enrolled and treated with a combination of antithymocyte globulin and cyclosporine. In multivariate analyses, lower white blood cell count was the most significant predictive marker of better response; patients with white blood cell count less than 2.0×10(9)/L showed a higher response rate than those with white blood cell count of 2.0×10(9)/L or more (P=0.0003), followed by shorter interval between diagnosis and therapy (P=0.01), and male sex (P=0.03). In conclusion, pre-treatment clinical and laboratory findings influence response to therapy. The finding that response rate worsens with increasing interval between diagnosis and treatment highlights the importance of prompt immunosuppressive therapy for patients with aplastic anemia.
More Related Videos
12:58Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:40Cell-mediated Immune Responses